Evidence map›Paper›PMID 38756447›Full record

ArticleFrontiers in genetics2024

Deciphering the role of apoptosis signature on the immune dynamics and therapeutic prognosis in breast cancer: Implication for immunotherapy.

Yunfang Yu, Xueyuan Jia, Sunyu Chen, Zijia Lai, Heran Deng, Yuqian Mo, Xinxin Xie, Zehua Wang, Ruichong Lin, Wenhao Ouyang and 2 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in genetics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Yunfang Yu *Faculty of Medicine, Macau University of Science and Technology, Taipa, Macao, China.
Xueyuan Jia *Faculty of Medicine, Macau University of Science and Technology, Taipa, Macao, China.
Sunyu Chen *School of Clinical Medicine, Guangdong Medical University, Zhanjiang, China.
Zijia Lai *School of Clinical Medicine, Guangdong Medical University, Zhanjiang, China.
Heran DengGuangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Phase I Clinical Trial Cent, Breast Tumor Center, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China.
Yuqian MoSchool of Clinical Medicine, Guangdong Medical University, Zhanjiang, China.
Xinxin XieGuangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Phase I Clinical Trial Cent, Breast Tumor Center, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China.
Zehua WangDivision of Science and Technology, Beijing Normal University-Hong Kong Baptist University United International College, Hong Kong Baptist University, Zhuhai, China.
Ruichong LinSchool of Computer Engineering, Guangzhou Huali College, Guangzhou, China.
Wenhao OuyangGuangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Phase I Clinical Trial Cent, Breast Tumor Center, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China.
Herui YaoGuangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Phase I Clinical Trial Cent, Breast Tumor Center, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China.
Jiannan WuGuangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Phase I Clinical Trial Cent, Breast Tumor Center, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

anti-PD-L1 therapyapoptosisbreast canceroncogenic processesprognostic model

Identifiers

PMID38756447
PMCPMC11097162

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.